Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Short-duration and accrual strategies better positioned amid abundant liquidity, says Devang Shah of Axis MF
21/08/2025
SBI’s home loan rate hike may delay purchases, impact first-time buyers the most : Yugen Infra
21/08/2025
JD Vance says Europe will have to take 'lion's share' of burden for Ukrainian security
21/08/2025
BofA names Faiz Ahmad, Mike Joo as new co-heads of investment banking, memo says
21/08/2025
US : At least 600 CDC employees are getting final termination notices, union says
21/08/2025
US attorney will no longer bring felony charges against people for carrying rifles or shotguns in DC
21/08/2025
